AIRLINK 74.60 Decreased By ▼ -0.65 (-0.86%)
BOP 5.14 Increased By ▲ 0.03 (0.59%)
CNERGY 4.50 Decreased By ▼ -0.10 (-2.17%)
DFML 33.00 Increased By ▲ 0.47 (1.44%)
DGKC 88.90 Decreased By ▼ -1.45 (-1.6%)
FCCL 22.55 Decreased By ▼ -0.43 (-1.87%)
FFBL 32.70 Decreased By ▼ -0.87 (-2.59%)
FFL 9.84 Decreased By ▼ -0.20 (-1.99%)
GGL 10.88 Decreased By ▼ -0.17 (-1.54%)
HBL 115.31 Increased By ▲ 0.41 (0.36%)
HUBC 136.63 Decreased By ▼ -0.71 (-0.52%)
HUMNL 9.97 Increased By ▲ 0.44 (4.62%)
KEL 4.63 Decreased By ▼ -0.03 (-0.64%)
KOSM 4.70 No Change ▼ 0.00 (0%)
MLCF 39.70 Decreased By ▼ -0.84 (-2.07%)
OGDC 138.96 Decreased By ▼ -0.79 (-0.57%)
PAEL 26.89 Decreased By ▼ -0.76 (-2.75%)
PIAA 25.15 Increased By ▲ 0.75 (3.07%)
PIBTL 6.84 Decreased By ▼ -0.08 (-1.16%)
PPL 122.74 Decreased By ▼ -2.56 (-2.04%)
PRL 27.01 Decreased By ▼ -0.54 (-1.96%)
PTC 14.00 Decreased By ▼ -0.15 (-1.06%)
SEARL 59.47 Decreased By ▼ -2.38 (-3.85%)
SNGP 71.15 Decreased By ▼ -1.83 (-2.51%)
SSGC 10.44 Decreased By ▼ -0.15 (-1.42%)
TELE 8.65 Decreased By ▼ -0.13 (-1.48%)
TPLP 11.51 Decreased By ▼ -0.22 (-1.88%)
TRG 65.13 Decreased By ▼ -1.47 (-2.21%)
UNITY 25.80 Increased By ▲ 0.65 (2.58%)
WTL 1.41 Decreased By ▼ -0.03 (-2.08%)
BR100 7,819 Increased By 16.2 (0.21%)
BR30 25,577 Decreased By -238.9 (-0.93%)
KSE100 74,664 Increased By 132.8 (0.18%)
KSE30 24,072 Increased By 117.1 (0.49%)

Australian shares rose on Tuesday by their most in two weeks, as biotech firm CSL Ltd led healthcare stocks higher and miners advanced on the back of an extended rally in iron ore futures.

The S&P/ASX 200 index settled 0.86% higher at 7,355 to notch its best session since Dec. 8, with all sectors except real estate, industrials and education closing in positive territory.

Healthcare stocks rallied 3.9% in their best session since August 2020. Kunal Sawhney, the chief executive officer at equity research firm Kalkine Group, said the gains were primarily fuelled by CSL's recovery.

CSL shares closed 4.9% higher in their second straight session of gains, after shedding 8.8% last week mainly due to a discounted capital raise to fund its acquisition of Vifor Pharma.

Omicron, Magellan Financial drag Australian shares lower

Among other gainers, Cochlear and Ramsay Health Care rose 3.9% and 3.1%, respectively.

"The broader optimism was seen to be ruling in favour of the healthcare sector," Sawhney said.

Analysts at Jefferies were also bullish on the sector on expectation that rising COVID-19 cases would contribute to pathology revenues.

Mining stocks gained 1.1%, with Rio Tinto and BHP Group rising 3.2% and 1.5% respectively, as iron ore prices extended their rally and hit multi-week highs on China demand hopes.

Energy stocks firmed 1.6%. Investment house Washington H Soul Pattinson And Co and Ampol rose 3.7% and 2%, respectively.

However, lithium explorer Pilbara Minerals fell 9% to be the top loser on the benchmark after it slashed its annual production forecast due to delays and shutdowns at project sites.

Meanwhile, minutes of the Reserve Bank of Australia's Dec. 7 meeting showed its board did not expect the Omicron variant to derail the country's economic recovery. The board also mulled how to wind up its bond buying programme given the rapid economic pickup.

Across the Tasman Sea, New Zealand's benchmark S&P/NZX 50 index climbed 0.71% to 12,856.87 despite the country delaying the reopening of its international border to late February.

Comments

Comments are closed.